Page 84 - World Journal of Laparoscopic Surgery
P. 84

LSG in Obesity and GERD
            Table 8: Endoscopic esophagitis between groups
                                                                               Groups
                                                             A                     B                  C
                                                      Preop      Postop     Preop     Postop     Preop     Postop
                                                      (N = 30)   (N = 30)  (N = 16)   (N = 16)  (N = 15)  (N = 15)
             Endoscopic esophagitis  No              30  (100)  13 (43.3)    0       2 (12.5%)     0      6 (40%)
                                  Grade A               0       11 (36.7)  2 (12.5)  4 (25.0)    1 (6.7)  6 (40.0)
                                  Grade B               0         5 (16.7)  8 (50.0)  5 (31.3)   4 (26.7)  3 (20.0)
                                             n (%)
                                  Grade C               0         1 (3.3)  2 (12.5)  3 (18.8)    7 (46.7)    0
                                  Grade D               0          0       4 (25.0)  1 (6.3)     3 (20.0)    0
                                  Erosive               0          0         0       1 (6.3)       0         0
             Total                                      30         30        16         16        15        15

            Table 9: Group A preop–postop difference
                                       Preop. data         Postop. data        Postop–preop difference     p value
                                       Mean (SD)           Mean (SD)               Mean (SD)               (<0.05)
             BMI                       44.0 (3.6)          32.2 (2.7)              −11.8 (3.1)              0.00
             GERD score                  8.1 (2.6)         12.9 (4.2)               +4.7 (4.8)              0.00
             Endoscopic esophagitis      0.0                 0.8 (0.8)              +0.8 (0.8)              0.00
             PPI intake                  0.0                 0.3 (0.6)              +0.3 (0.6)              0.01

            esophagitis. Intake of PPI medications was occasionally in 26.2% and   A comparison between patients in groups A and B (Table 5)
            daily in 19.7%. These results are matching with other reports. 1,2,5,6  revealed that there was no effect of preexisting GERD on the weight
               Group A patients showed significant worsening of GERD scores   loss after LSG.
            (+4.7 ± 4.8) and endoscopic esophagitis after LSG (postoperative   Another comparison between patients in groups B and C
            de novo GERD) (Table 9).                           (Table 6) revealed more improvement in GERD scores, PPI intake,
               The above results are matching with what was reported by   and endoscopic esophagitis for group C patients, the above results
                                       3
                    8
                          1
            Jorge et al.,  Halim,  and Ramon et al.  that patients after LSG have   declared that RYGB is more effective in multifactorial control against
            factors that enhance de novo GERD such as lost angle of His, crural   GERD persistence.
            dissection, disturbed sling fibers, the excised pad of fat, increased   In this study, Table 7, we found a positive weak to an intermediate
            intragastric pressure, delayed gastric emptying, weak LES, and   correlation between GERD score and endoscopic esophagitis.
            possible migration of gastric tube toward the negatively pressured   That may be interpreted as clinical symptoms alone cannot be
            thoracic cavity.                                   considered enough for GERD evaluation especially with patients
               On the other hand, some patients after LSG with preexisting   giving symptoms of preexisting GERD.
            GERD (group B, Table 3) may show some benefits in GERD
            improvement. Those patients with preexisting GERD received LSG.  conclusIon
            The significant improvement in GERD scores is synchronous with   Treating obesity in patients with concomitant GERD should be taken
            statistically non-significant worsening of endoscopic esophagitis.   carefully. Laparoscopic sleeve gastrectomy operation seems to be
            One case in this group (6.3%) showed erosive esophagitis   truly a refluxogenic procedure, while RYGB should be considered as
            (Tables 3 and 8). Although it is still statistically non-significant   better alternatives to avoid postoperative worsening of GERD and
            but can be considered clinically significant, samples with a   degree of esophagitis. Upper GI endoscopy should be considered as
            bigger number can be more beneficial in declaring the statistical   a routine preoperative and postoperative-assessment tool, especially
            significance. The above data in group B can be explained by   for cases with clinically suspected GERD. Further studies with a bigger
            decreased intra-abdominal pressure after weight loss, improved   number of cases are recommended to stabilize this concept.
            gastric emptying in some cases, and decreased ability of acid
            production. 3                                      references
               Group C patients (preexisting GERD  patients received  RYGB,
            Table 4), those patients showed improvement in GERD scores     1.  Daher HB, Sharara AI. Gastroesophageal reflux disease, obesity, and
            (−8.7 ± 2.2). Also, there was a significant improvement in esophagitis   laparoscopic sleeve gastrectomy: the burning questions. World J
                                                                    Gastroenterol 2019;25(33):4805–4813. DOI:10.3748/wjg.v25.i33.4805.
            grade (−2.3 ± 1.1) and PPI intake (−1.1 ± 0.6).      2.  Navarini D, Madalosso CAS, Tognon AP, et al. Predictive factors of
                                                     7
               These results agree with that reported by Zaina et al.  that RYGB   gastroesophageal reflux disease in bariatric surgery: a controlled
            is a feasible option used more frequently to treat bariatric cases   trial comparing sleeve gastrectomy with gastric bypass. Obes
            with concomitant GERD.                                  Surg2020;30(4):1360–1367. DOI:10.1007/s11695-019-04286-5.



            270   World Journal of Laparoscopic Surgery, Volume 15 Issue 3 (September–December 2022)
   79   80   81   82   83   84   85   86   87   88   89